Disclosure of notification received from Mawer

Group 1 - Fagron received a notification from Mawer Investment Management Ltd regarding a change in shareholding, specifically crossing the disclosure threshold of 5% downwards [1][6] - On 29 August 2025, Mawer Investment Management Ltd held a total of 3,632,837 voting rights, which represented 4.96% of the total voting rights based on a denominator of 73,313,904 [6] - The notification indicates that the change in shareholding was due to the disposal of voting securities or voting rights [6] Group 2 - Fagron is a leading global company in pharmaceutical compounding, providing personalized medicine to various healthcare facilities in over 35 countries [3] - The company is listed on Euronext Brussels and Euronext Amsterdam under the ticker symbol 'FAGR' [4] - Fagron's operational activities are managed through its Dutch subsidiary, Fagron BV, which is headquartered in Rotterdam [4]